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A B S T R A C T
Introduction: Autonomic instability is considered a contributing factor in sudden unexpected death in
epilepsy (SUDEP). The aim of this pilot study was to measure parasympathetic activity in sub-clinical
seizures to investigate autonomic instability.
Materials and methods: A prospective study based on Video-electroencephalography (EEG)/electrocar-
diography (ECG)/oxygen saturation (SAO2) recordings was selected from patients having sub-clinical
seizures during stage 3 or 4 sleep. We analysed R–R intervals in the ECG from 1-min prior to the
electrographic onset to the end of sub-clinical seizures. Matched non-ictal R–R baseline measurements
were selected from stages 3 or 4 sleep. R–R interval data were analysed using NeuroScope software
providing a cardiac index of parasympathetic activity (CIPA). BioSignal short-term heart rate variability
(HRV) software was used to analyse the same R–R interval data previously analysed using NeuroScope
except that sub-clinical seizure data was embedded within 5-min epochs and compared to 5-min epochs
of non-ictal measurements.
Results: A total of 33 sub-clinical seizures were recorded from 11 patients comprising 19 generalised sub-
clinical seizures (2 patients), 9 right temporal lobe sub-clinical seizures (5 patients) and 5 left temporal
lobe sub-clinical seizures (4 patients) were compared to matched non-ictal measurements.
Parasympathetic activity was clearly altered during total sub-clinical seizures in terms of the CIPA
(p < 0.001) and 5-min HRV high frequency (HF) % (p = 0.026) measures. Generalised sub-clinical seizures
resulted in increased cardiac parasympathetic activity whereas temporal lobe seizures were associated
with a decrease in parasympathetic activity.
Conclusion: This pilot study indicates that parasympathetic changes occur during sub-clinical seizures.
Generalised sub-clinical seizures may be associated with more autonomic instability compared to
temporal lobe sub-clinical seizures.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Sudden unexpected death in epilepsy (SUDEP) has been deﬁned
as ‘sudden, unexpected, witnessed or un-witnessed, non-traumatic
and non-drowning death in patients with epilepsy, with or without
evidence of a seizure and excluding documented status epilepticus,
where post-mortem examination does not reveal a toxicological or
anatomical cause of death’.1 No evidence of the mechanisms
underlying SUDEP have been proven but alteration of autonomic
activity in association with seizures and sub-clinical seizures may
lead to cardiac or respiratory instability and is believed to be one
the underlying causes of SUDEP.1–6 It has also been postulated that
a predisposed patient could become a victim of SUDEP if there is a
combination of reduced sympathetic tone during sleep, ictal* Corresponding author. Tel.: +44 0131 537 2098.
E-mail addresses: ruth.brotherstone@luht.scot.nhs.uk, r.brotherstone@sky.com
(R. Brotherstone), ailsa.mclellan@luht.scot.nhs.uk (A. McLellan).
1059-1311/$ – see front matter  2012 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2012.03.011bradyarrthymia or extreme changes in heart rate resulting in
autonomic instability. Ictal bradyarrthmia and/or sinus arrest have
vagally mediated involvement during seizure discharges.7
Autonomic manifestations during seizures are common.
However, it is not possible to quantify the effects of cardiac vagal
tone and heart rate variability during most clinical seizures as
changes in consciousness, body position and physical exertion all
alter sympatho-vagal balance. Therefore, the aim of this study is to
investigate changes in cardiac vagal tone and heart rate variability
during sub-clinical seizures. Sub-clinical seizures have been
deﬁned as ‘‘electroencephalographic ictal-like patterns without
any disturbance of motor, sensory and conscious functions in the
wake patient and without any movement or arousal during the
sleep patient’’.8Beat to beat variation of heart rate is partly due to
inﬂuences of the autonomic nervous system innervating the sinus
node. Loss of this variation is widely considered to be a measure for
risk of sudden death in myocardial infarction patients.9–12
Cardiac vagal tone is a measurement of parasympathetic
activity and is analysed in this study using NeuroScope softwarevier Ltd. All rights reserved.
Table 1
Demographics of study patients, sub-clinical seizures and duration.
Patient ID Gender Age Epilepsy classiﬁcation Etiology Sub-clinical seizures Anti-epileptic medication
1 Male 34 years 11 months Cryptogenic right temporal seizures Nil One 146 s Carbamazepine
2 Male 14 years 5 months Symptomatic right focal seizures Auto-immune
encephalitis
Five 260.4  42.2 s Sodium valproate,
carbamazepine, clobazam
3 Female 27 years 9 months Cryptogenic right temporal focal seizures Nil One 232 s Nil. New diagnosis.
Commenced on AEDb
after video-EEG
4 Male 20 years 9 months Symptomatic right temporal lobe seizures Poly-microgyria
medial and inferior
temporal lobe
One 139 s Sodium valproate,
carbamazepine
5 Male 3 years 1 month Symptomatic right temporal lobe seizures DNETa autistic
spectrum
disorder
One 259 s Nil. Commenced on AEDb
after videotelemetry
6 Female 22 years 8 months Cryptogenic left temporal lobe seizures Nil One 63 s Nil. Commenced on AEDb
after video-EEG
7 Female 11 years 3 months Cryptogenic left temporal lobe seizures Nil. Two 278  99 s Carbamazepine
8 Male 49 years 7 months Cryptogenic left temporal lobe seizures Nil One 210 s Carbamazepine
9 Female 60 years 3 months Symtomatic left temporal lobe sezures Mesial temporal
sclerosis
One 218 s Nil. Commenced
after video-EEG
10 Male 5 years 11 months Cryptogenic myoclonic astatic epilepsy Nil Eleven 218.3  98 s Phenobarbitone topiramate
11 Male 5 years 9 months Cryptogenic myoclonic astatic epilepsy Nil Eight 110.38  37.6 s Sodium valproate, clobazam
a DNET, dysembryoplastic neuroepithelial tumour.
b AED, anti-epileptic drug.
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measuring tonic vagal activity. The NeuroScope13 measures
cardiac vagal tone by analysing R–R interval measurements and
comparing incoming QRS signal to a previously acquired QRS
template. This innovative device measures the delay in the next
cardiac cycle induced by baroreceptor stimulation, which is
proportional to baroreceptor strength and duration.14 Since the
NeuroScope quantiﬁes the effects of the baroreﬂex on the pulse
intervals on a beat-by-beat basis, it can output a cardiac index of
parasympathetic activity (CIPA) as real-time measurements of
reﬂex vagal activity. CIPA is deﬁned as ‘‘the increase in pulse
interval per unit increase in systolic pressure’’15 and measured on
an arbitrary scale of 1–10 based on studies of supine resting
healthy adults in response to atropine and uses a zero reference
point. An output measurement of 1–4 units represents low cardiac
index of parasympathetic activity (CIPA) and 5–10 units represents
the normal range of CIPA in adults.16 However, a review article by
McKechnie et al.17 suggested that the upper limit of normal CIPA
should be extended.
BioSignal18 heart rate variability (HRV) analysis is the
comparison of sequential R–R intervals and changes in interval
are plotted in the time domain as a tachogram. The time domain R–
R interval tachogram is then digitally interpolated for spectrum
estimation as a frequency domain. This is displayed separately for
Welch’s Periodogram fast Fourier transform (FFT) and an auto-
regressive modelling based spectrum (AR). Frequency oscillations
are quantiﬁed and displayed as a power spectral density once any
leakage current frequencies are removed using a Hamming
window ﬁlter. A power spectral density of very low frequency
(VLF, 0–0.04 Hz), low frequency (LF, 0.04–0.15 Hz) and high
frequency (HF, 0.15–0.4 Hz) is produced. LF is believed to be a
mixture of sympathetic and parasympathetic activity and is
therefore difﬁcult to interpret. %HF will be considered in this
study, as HF is believed to be a measure of mainly parasympathetic
tonic vagal activity.19
2. Materials and methods
Patients who were already familiar with video-EEG/ECG/SAO2
telemetry and not anxious about the test were invited to take part
in this ethically approved prospective study over a 24-month
period (Table 1). In patients who had sub-clinical seizures, strictcriteria ensured that selected sub-clinical data and baseline data
were restricted to stage 3 or 4 sleep20,21 or ‘‘N3’’ or ‘‘N4’’stages as
deﬁned by the American Academy of Sleep Medicine reported by
Iber et al.22 A constant resting slow wave sleep state during stages
3 and 4 was chosen to compare baseline and sub-clinical seizure
parasympathetic activity during regular respiration. Control data
was obtained using each patient’s baseline measurements to
compare to the sub-clinical seizure data during the same stage of
slow wave sleep. Drowsiness or light sleep was considered to be
too brief and REM sleep was avoided as withdrawal of vagal tone is
described during REM sleep particularly in men.23 Sub-clinical
seizures were identiﬁed electrographically from 23 scalp electro-
des placed in accordance to the International 10:20 system and
veriﬁed as having no clinical accompaniment by high resolution
time-integrated video. Electroencephalography was also used to
identify slow wave sleep and that the trace was void of arousals or
movement. Manual selection of R–R interval sections ensured that
the trace was artefact free and any ectopic beats were excluded.
The sampling rate of the physiological ECG signal was 500 Hz and
5 kHz post acquisition by the NeuroScope. All patients were in
sinus rhythm throughout. No patients were known to have
diabetes or coronary heart disease that may alter HRV ﬁndings.
Oxygen saturation was measured using an LNOP forehead Masimo
sensor with a digital signal output 1/s displayed simultaneously
with the EEG/ECG telemetry trace.
2.1. Video-EEG/ECG/SAO2 telemetry data for NeuroScope analysis
The start of the ECG sample was taken 1-min prior to the sub-
clinical electrographic change to ensure that any cardiac vagal tone
changes just prior to sub-clinical seizure onset were not omitted.
The end of the sample was taken when the sub-clinical seizure
ended electrographically and the resting trace was resumed. R–R
intervals were counted manually for each study and a matched
count was selected from the resting record in sleep stages 3 or 4
from the same patient as control baseline measurements for the
comparison of sub-clinical seizure data.
2.2. Electrocardiographic conversion for NeuroScope analysis
Clipped EEG/ECG telemetry data of the selected sub-clinical
seizures and matched counted EEG/ECG baseline data were
Fig. 1. Bland and Altman plot of CIPA associated with right temporal sub-clinical
seizures. CIPA difference (baseline minus sub-clinical) versus CIPA average. Limits
of agreement are 7.00 and 14.3.
Fig. 2. Bland and Altman plot of CIPA associated with left temporal seizures. CIPA
difference (baseline minus sub-clinical) versus CIPA average. Limits of agreement
are 7.8 and 16.6.
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The ECG channel was then extracted from each ﬁle and converted
by NeuroScope software for CIPA analysis. CIPA analysis produced
Excel spreadsheets of CIPA measurement for each beat with R–R
interval data.
2.3. Video-EEG/ECG/SAO2 telemetry data for BioSignal HRV
The Task Force of the European Society of Cardiology and the
North American Society of Pacing and Electrophysiology19
standards state that 5-min epochs should be analysed for ‘short
term’ HRV. Each section of R–R interval previously measured for
CIPA NeuroScope analysis during sub-clinical seizures and baseline
measurements were embedded within a 5-min clipped sample to
enable BioSignal HRV analysis. As sub-clinical seizures tend to be
much briefer than 5 min the sample also included some resting and
post-ictal phase data. R–R intervals were manually measured from
these ﬁles and entered onto an Excel spreadsheet. These Excel
spreadsheets were then converted to Text (MSDOS) ﬁles and
imported into BioSignal HRV software for analysis.
2.4. Statistical analysis
Statistical analyses of total CIPA sub-clinical seizure data was
compared with total baseline data using Minitab version 14. Tailed
distribution of total data meant that non-parametric analysis was
required using Wilcoxon paired sample testing. Co-efﬁcient of
variation is a normalised measure of dispersion or scatter and was
used to analyse the dispersion of data in CIPA in right and left
temporal lobe sub-clinical seizures and generalised sub-clinical
seizures. The results were corrected for multiple measurements
using Bonferroni correction. BioSignal biomarkers of HF, LF, VLF,
SDNN (Standard Deviation of Normal-to-Normal Beat), SDNN50
(Standard Deviation of Normal-to-Normal beat 50 millisecond
count) and RMSSD (Root Mean Square of Successive Differences)
sub-clinical measurements were compared to baseline measure-
ments. Data for temporal lobe sub-clinical seizures was compared
with that for generalised sub-clinical seizures. Limits of agreement
were calculated using Bland and Altman plot24,25 deﬁned as the
mean difference  twice the standard deviation of the differences.
Inter and intra-observer agreement of manual R–R measurement for
5-min HRV were analysed using students paired t-tests.
3. Results
Thirty-three sub-clinical seizures (mean duration 191.1 
136.4 s, ranging from 63 to 340 s) were analysed from 11 patients
with an age range 3 years 1 month to 60 years 3 months (mean age
23.09  18.73 years). The 11 patients were selected from 50 patients
who took part in a larger physiological study. The remaining 39
patients either did not have sub-clinical seizures or have sub-clinical
seizures that did not occur during slow wave sleep and therefore
could not be included in the study. Six patients were adults (3 male
and 3 female, mean age 35.81  15.99 years) and 5 patients were
paediatric (4 male and 1 female, mean age 7.81  4.8 years). Nine
sub-clinical seizures were derived from and conﬁned to the right
temporal lobe (5 patients: 3 adults – 3 seizures and 2 children – 6
seizures) and ﬁve sub-clinical seizures were derived from and
conﬁned to the left temporal lobe (4 patients: 3 adults – 3 seizures
and 1 child – 2 seizures). Nineteen generalised sub-clinical seizures
were analysed from two paediatric patients.
HFms2 represents high frequency power but using this unit of
measurement resulted in large variations in values with substan-
tial standard deviations and were hard to quantify and compare for
both inter and intra-subject data. CIPA, HF% and HFms2were tested
using a Pearson correlation co-efﬁcient. CIPA results were moreclosely correlated to HF% (p < 0.001) than HFms2 (p = 0.359).
Therefore HF% is described in this study instead, measuring the
proportion of high frequency HRV in relation to low frequency and
very low frequency. No changes in oxygen saturation were
detected during sub-clinical seizures.
3.1. NeuroScope CIPA
A decrease in CIPA indicates reduced vagal tone and usually
results in an increase in heart rate and vice versa. Overall, CIPA
decreases from baseline CIPA (8.16  6.33) to CIPA in sub-clinical
seizures (6.94  5.05) (p < 0.001). Sub-clinical seizures arising from
the right temporal lobe show a decrease (mean difference 3.64, Fig. 1)
from baseline CIPA (12.71  5.34) to CIPA in sub-clinical seizures
(9.08  5.36), p < 0.001. Similarly, in sub-clinical seizures arising
from the left temporal lobe there is also a decrease in CIPA (mean
difference 4.39, Fig. 2) from baseline CIPA (14.34  6.82) to sub-
clinical CIPA (9.95  6.94) p < 0.001. Conversely, in generalised sub-
clinical seizures there is an increase in CIPA (mean difference 1.11,
Fig. 3) from baseline CIPA (3.74  1.54) to sub-clinical CIPA
(4.84  2.82), p < 0.001. Sub-clinical seizures arising from the right
temporal lobe have a co-efﬁcient of variation of 37.8% (CI 15.4, 60.3)
increasing from baseline measurements (22.1% CI 17.2, 26.9) (Fig. 4).
An increase in coefﬁcient of variation is also seen from sub-clinical
seizures arising from the left temporal lobe of 44.4% (CI 12.7, 76.0)
increasing from baseline measurements (29.4% CI 7.8, 50.9) (Fig. 4).
Conversely, the co-efﬁcient of variation difference from generalised
Fig. 3. Bland and Altman plot of CIPA associated with generalised sub-clinical
seizures. CIPA difference (baseline minus sub-clinical) versus average. Limits of
agreement are 6.8 and 4.6.
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20.0, 34.6) from baseline measurements (50.8% CI 49.7, 52.0) (Fig. 4).
3.2. Comparison of adult data and paediatric data
This pilot study included 5 paediatric patients (2 patients with
generalised sub-clinical seizures, 2 patients with right temporal
and 1 patient with left temporal lobe sub-clinical seizures) and 6
adult patients (3 patients with right temporal lobe and 3 patients
with left temporal lobe sub-clinical seizures). No generalised sub-
clinical seizures were recorded from the adult patients to compare
to the CIPA results from two paediatric patients who had a total of
19 generalised sub-clinical seizures with mean CIPA increasing
from 3.73 to 4.84 (p < 0.001). A decrease in CIPA occurred in three
paediatric patients having focal sub-clinical seizures. For two
patients with right temporal lobe sub-clinical seizures mean CIPA
decreased from 11.79 to 9.25 (p = 0.006). In the patient with left
temporal lobe sub-clinical seizures mean CIPA decreased from
17.91 to 14.60 (p = 0.682).
Similar to the paediatric group, a decrease in CIPA occurred in
all focal seizures in the adult group. Mean CIPA decreased from
15.83 to 8.50 in three adult patients with right temporal lobe sub-
clinical seizures (p = 0.010). Similarly mean CIPA decreased from
10.09 to 4.42 in three adult patients with left temporal sub-clinical
seizures (p = 0.014).Fig. 4. Interval plot of coefﬁcient of variation for CIPA in right baseline 22.1%
(n = 2688), right sub-clinical 37.8% (n = 2688), left baseline 29.4% (n = 1307), left
sub-clinical 44.4% (n = 1307) and generalised baseline 50.8% (n = 4588), generalised
sub-clinical 27.3% (n = 4588).3.3. BioSignal SDNN50
When SDNN50 mean counts are considered for all patients there
is no signiﬁcant difference between total baseline counts
(65.9  76.3) and sub-clinical seizure (64.5  58.2) data (p = 0.932).
However, differences are detected when sub-clinical seizure types are
analysed separately. There are generally smaller counts during baseline
and sub-clinical seizure counts for patients with refractory generalised
epilepsy compared to analysis of counts for patients with temporal lobe
seizures. Baseline mean counts of SDNN50 for right temporal sub-
clinical seizures for baseline measurements (133.2  35.9) reduce to
sub-clinical (106.4  51.8) (p = 0.016). Left temporal lobe sub-clinical
seizures SDNN50 shows a similar reduction from baseline
(157.2  91.6) to sub-clinical (113.4  79.6) (p = 0.029). Generalised
sub-clinical seizures have comparatively much lower SDNN50 counts
compared to temporal lobe counts with baseline SDNN50
(9.947  0.815) to sub-clinical (31.68  27.29) (p < 0.001), and this
would indicate that there is generally less beat-beat variability in
this group.
3.4. SDNN and RMSSD
SDNN is the square root of variance and is mathematically equal
to the total power of spectral analysis and represents all the cyclic
components contributing to HRV.19 Statistically signiﬁcant differ-
ences are seen for total sub-clinical seizures (0.05  0.03) compared
to baseline measurements (0.04  0.02) (p < 0.001) and generalised
sub-clinical seizures (0.046  0.029) (p < 0.001) compared to base-
line measurements (0.03  0.018) after Bonferroni correction. SDNN
for right (p = 0.304) and left (p = 0.02) temporal lobe seizures are not
considered statistically signiﬁcant after correction for multiple
measurements.
RMSSD is an estimate of HRV short-term components.
Following Bonferroni correction, the only statistically signiﬁcant
change (p = 0.003) is attributed to generalised sub-clinical seizures
(40.29  30.53) compared to baseline measurements (30.53  20.9).
Right temporal lobe sub-clinical seizures (60.2  38.2) compared to
baseline (59.8  13.09) (p = 0.97) and left temporal lobe sub-clinical
seizures (73.2  42.3) compared to baseline measurements
(65.4  24.07) (p = 0.466) are not statistically signiﬁcant.
This result suggests that in this pilot study, SDNN, RMSSD and
standard deviation during generalised sub-clinical seizures are
smaller indicating less short-term variability and are more
statistically signiﬁcant compared to these biomarkers during
temporal lobe seizures.
3.5. HF%, LF% and VLF% HRV spectral frequencies
HF% HRV is believed to represent parasympathetic activity.
There is a reduction of parasympathetic activity from total baseline
HF% measurements (45.6  23.04) compared to total sub-clinical
seizures (36.3  15.25) (p = 0.026). For right temporal lobe sub-
clinical seizure data there is a decrease in baseline HF% (37.8  7.98)
reducing to sub-clinical HF% (28  17.36) (p = 0.042). Left temporal
lobe sub-clinical seizure data similarly reduces from baseline HF%
(47.2  34.5) to sub-clinical HF% (25.4  22.4) (p = 0.062). However,
generalised data shows an increase in parasympathetic activity from
baseline HF% (24.3  24.96) to sub-clinical HF% (32.8  10.58) but
does not reach statistical signiﬁcance (p = 0.512) (Table 2).
LF% HRV is considered to represent sympathetic and, to some
extent, includes parasympathetic activity. Differences are seen
during generalised sub-clinical seizures compared to temporal
lobe sub-clinical seizures. An increase in LF% HRV occurs during
generalised sub-clinical seizures (51.4  14.8) compared to baseline
measurements (26.1  0.56). In contrast, decreases in LF% are noted
during right sub-clinical seizures (38.4  31.45) compared to baseline
Table 2
Comparison of 33 baseline and 33 sub-clinical CIPA, HRV %HF, %LF and SDNN50 during total, right, left and generalised data.
Biomarker Baseline Sub-clinical Wilcoxon p = /< Bonferroni
CIPA during total data 8.16  6.33 6.94  5.05 0.001 0.001
CIPA during right temporal lobe data 12.71  5.34 9.08  5.36 0.001 0.005
CIPA during left temporal lobe data 14.34  6.82 9.95  6.94 0.001 0.01
CIPA during generalised data 3.74  1.54 4.84  2.82 0.001 0.002
HRV %HF (and %LF) during total baseline and sub-clinical data 45.64  23.04
(38.01  17.92)
36.33  15.25
(34.86  27.36)
0.04
(0.699)
0.001
HRV %HF% (and %LF) during right temporal lobe activity 37.8  7.98
(48.14  8.14)
28.00  17.36
(38.4  31.45)
0.079
(0.449)
0.005
HRV %HF (and %LF) during left temporal lobe activity 47.2  34.5
(31.32  25.6)
25.4  22.4
(22.17  26.16)
0.143
(0.53)
0.01
HRV %HF (and %LF) during generalised activity 24.3  24.96
(26.1  0.56)
32.8  10.58
(51.4  14.8)
0.991
(0.242)
0.002
SDNN (and RMSSD) during total data 0.04  0.02
(38.5  23.1)
0.05  0.03
(45.7  31.7)
0.001
(0.037)
0.001
SDNN (and RMSSD) during right temporal lobe activity 0.06  0.017
(59.8  13.09)
0.068  0.03
(60.2  38.2)
0.304
(0.97)
0.005
SDNN (and RMSSD) during left temporal lobe activity 0.068  0.01
(65.4  24.07)
0.092  0.02
(73.2  42.3)
0.02
(0.466)
0.01
SDNN (and RMSSD) during generalised activity 0.03  0.018
(30.53  20.9)
0.046  0.029
(40.29  27.9)
0.001
(0.003)
0.002
SDNN50 count during total data 65.9  76.3 64.5  58.2 0.932 0.001
SDNN50 count during right temporal lobe activity 133.2  35.9 106.4  51.8 0.016 0.005
SDNN50 count during left temporal lobe activity 157.2  91.6 113.4  79.6 0.029 0.01
SDNN50 during generalised activity 9.94  0.815 31.68  27.29 0.001 0.002
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pared to baseline (31.32  25.6). Statistical signiﬁcance is not
demonstrated for LF% in any group.
VLF% HRV physiological representation is largely unexplained
but considered to be indicative of rennin–angiotensin–aldosterone
hormonal interplay on the autonomic nervous system. No
statistically signiﬁcant results are seen from changes in this
spectral frequency.
3.6. Effects of anti-epileptic medication on CIPA
No statistically signiﬁcant differences in CIPA are found when
comparing baseline to sub-clinical seizure results from patients
being treated by anti-epileptic medication (p = 0.407) with those
who were not receiving any anti-epileptic medication (p = 0.658).
Seven patients (3 adults, 4 paediatrics) receiving monotherapy (3
patients) and polytherapy (4 patients) had similar baseline CIPA
measurements (3.83  2.94) compared to four patients (3 adults, 1
paediatric) not receiving anti-epileptic medication (3.43  1.68).
3.7. Inter and intra-observer agreement
Inter-observer agreement of identical R–R measurements
(n = 369) was highly correlated with no statistical signiﬁcant
difference between observers (p = 0.809). Intra-observer agree-
ment of identical R–R measurements was even more closely
correlated and again no statistical signiﬁcant difference found
between runs of observations (p = 0.976).
4. Discussion
‘The last two decades have witnessed the recognition of a
signiﬁcant relationship between the autonomic nervous system
and cardiovascular mortality, including sudden cardiac death.
Experimental evidence for an association between the propensity
for lethal arrhythmias and signs of either increased sympathetic or
reduced vagal activity has spurred efforts for the development of
quantitative markers of autonomic activity. Heart rate variability
represents one of the most promising such markers’.19 The
‘‘lockstep phenomenon’’ was proposed by Lathers et al.26 and
proved synchronisation between epileptogenic ‘‘sub-convulsant’’discharges with abnormal sympathetic and vagal neural dis-
charges with cardiac arrhythmia in anaesthetised cats. They
suggested that the lockstep phenomenon of synchronisation of
epileptogenic discharge with cardiac sympathetic neural discharge
could be a contributing factor of SUDEP. Variability of successive
R–R intervals is generally considered to be an important protective
mechanism of the autonomic nervous system being able to
respond to sudden cardiovascular demands.12,27 Loss of this
variability increases the risk of sudden cardiac death and reduced
HRV is a measure of risk stratiﬁcation for myocardial infarction
patients.9–12 Bigger et al.9 describe sudden cardiac death occurring
within 2.5 years post myocardial infarction for approximately 50%
of patients. The Framingham Heart Study reported by Tsuji et al.28
indicates that low HRV is an independent marker of all causes of
mortality in coronary events. Bilchick and Berger29 reviewed HRV
literature and described results from the Multicenter Post
infarction Group (1987) that SDNN was the strongest univariant
predictor of mortality from reduced HRV culminating from a
combination of sustained increased sympathetic tone and vagal
withdrawal, increasing the risk of ventricular ﬁbrillation.
Clear altered parasympathetic activity is observed in this pilot
study for whole group analysis when comparing sub-clinical
seizures data to baseline measurements. There is a decrease in
cardiac vagal tone in total sub-clinical seizures (CIPA, p < 0.001
and 5-min HF%, p = 0.026). One previous study,30 reported
‘‘minimal’’ changes of ‘‘lower HRV’’ from left sub-clinical seizures
than from right sub-clinical seizures. However, the study by this
group is methodologically limited as 10-s epochs for HRV and is
considered too short to quantify HRV fully unless vagal tone is
measured using the NeuroScope.31 Additionally, the SDNN was
calculated over 10 s, which is also too brief a duration to perform
this time domain analysis effectively. As the period of monitoring
decreases, SDNN will estimate a shorter cycle length and for this
reason the minimum European standard period of monitoring is
5 min.19
4.1. CIPA versus HRV
CIPA measures efferent vagal tone from baroreceptor feedback
and HRV HF measures modulations of parasympathetic tonic
activity. Bigger et al.32 found only a moderate correlation between
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explain that this is expected because baroreﬂex sensitivity is a
‘‘vagal stress test’’ measuring transient changes on a beat by beat
basis compared to summated tonic activity over 24-h periods
(divided into 5-min epochs). A large prospective study,34 found
that Baroreﬂex sensitivity and SDNN have similar prognostic
values but are stronger when used in combination.
4.2. Do generalised sub-clinical seizures pose a greater risk of
autonomic nervous system deregulation than temporal lobe seizures?
In this pilot study, there are statistically signiﬁcant increases in
cardiac vagal tone, smaller changes in overall HRV (SDNN), short
term HRV (RMSSD), and lower counts of SDNN50 in generalised
sub-clinical seizures compared to sub-clinical seizures arising
from the temporal lobes. Persson et al.35 analysed long term resting
24-h HRV of 22 newly diagnosed patients with epilepsy prior to
treatment with a control group and found no statistically
signiﬁcant differences between the two groups. However, repeated
seizures over a longer term are reported to have an effect on
autonomic cardiac regulation and patients with chronic epilepsy
have an increased morbidity and higher rates of SUDEP mortality
than patients with newly diagnosed epilepsy.36,37 Harnod et al.37
analysed heart rate variability in children with refractory
generalised epilepsy and they concluded that lower HRV was
found during the inter-ictal period. Bulent et al.38 also describe
how long term abnormalities in the autonomic nervous system
from repeated seizures can cause a temporary impairment in
autonomic functions by each epileptic discharge having an effect
upon limbic structures, amygdala and periamygdaloid piriform
cortex. Additionally, this group found that autonomic dysfunction
became more marked in the post-ictal period compounding an
already existing dysfunction. Nouri et al.39 describes how damage
to the myocardium can occur when exposed to frequent increases
of plasma catecholamines. This damage to the myocardium can
then cause areas of ﬁbrosis and render the myocardium more likely
to trigger cardiac arrhythmias. During epileptic seizures, tachy-
cardia is common due to vagal withdrawal and sympathetic
catecholamic release. Repeated seizures caused by refractory
epilepsy may theoretically also lead to damage to the myocardium
and result in reduced HRV and be more prone to cardiac
arrhythmias.
Both patients presenting with generalised sub-clinical seizures
in this study had severe intractable epilepsy and proposed effects
of repeated seizures on the autonomic nervous system36,37may be
a contributing factor of increased cardiac vagal tone and reduced
HRV compared to localisation related epilepsy patients in
this study.
La Rovere et al.34 commented that patients who have low vagal
tone have a reduced capability to antagonise sympathetic
activation through vagal mechanisms and describe a peak in
mortality during early morning hours when there is a surge of
sympathetic activity. This may be a contributing factor during fatal
nocturnal seizures.
Concordant with Evrengul et al.36 and Harnod et al.37 this study
demonstrates a lower inter-ictal or ‘‘baseline’’ HRV HF% in
patients with generalised epilepsy compared to patients with
temporal lobe seizures. R–R interval data during generalised sub-
clinical seizures is different compared with R–R interval data
during right or left temporal lobe sub-clinical seizures. General-
ised sub-clinical seizures show a mean increase in R–R interval
from 628.9 to 686.9 ms (p < 0.001) indicating a decrease in heart
rate. Decreases in R–R coefﬁcient of variation occurs during
generalised sub-clinical seizures (5% baseline to 4.3% sub-
clinical), compared to increases in coefﬁcient of variation of R–
R interval during right temporal lobe sub-clinical seizures (7.3%baseline to 10.6%) and R–R interval data during left temporal lobe
sub-clinical seizures (8.6% baseline to 15.8%) demonstrate that
decreased HRV occurs during generalised sub-clinical seizures but
is not found during sub-clinical seizures arising from temporal
lobes.
4.3. A proposed SUDEP mechanism
Autonomic instability and reduced variability of successive
beats may put a pre-disposed individual at more risk of cardiac
arrhythmia during sleep in the event of a seizure when vagal tone
is already high.40 During a seizure, it would be expected that the
autonomic nervous system responds by decreasing vagal tone and
increasing heart rate ready to meet the physical demands of the
seizure. However, this study would indicate that in some cases of
generalised seizures there could instead be an inappropriate initial
further increase in vagal tone resulting in a further initial decrease
in heart rate potentially leading to ictal bradyarrythmia. Clinical
generalised seizures are then characteristically followed by a
massive acceleration of heart rate and marked catecholaminergic
activity at the myocardium. This initial mismatch between vagal
tone and seizure demand could make the myocardium vulnerable
leading to possible cardiac arrhythmia and then SUDEP in some
pre-disposed individuals with low heart rate variability. Massive
sympathetic discharge can trigger fatal cardiac arrthythmias
during seizures.39,41 O’Regan and Brown42 also describe a rapid
but short lived rise in cardiac vagal tone associated with some
seizures but consider that this may be an inbuilt mechanism to
protect the myocardium from possible fatal cardiac arrhythmias
caused by unbridled sympathetic or massive catecholamine
activity. Delamont et al.43 also describe an increase in cardiac
parasympathetic activity just prior to secondary generalised
complex partial seizures and proposed that pre-ictal elevation of
cardiac sympathetic activity may be a marker for secondary
generalised seizures.
A study by Vaughn et al.7 recorded asystole lasting 3–17 s
during ﬁve generalised tonic clonic seizures in an infant. They
found increases in both sympathetic and parasympathetic spectral
frequencies and therefore suggested epileptic induced asystole
resulted from both arms of autonomic outﬂow being activated.
However, it is not clear from Vaughn et al.’s study at which point in
the clinical seizure the 10-s epoch was selected, whether artefact-
free ECG was possible during a clinical seizure and how
interpretation of HRV analysis was possible during a clinical
epileptic attack when complicated by physical exertion, change in
body position and temperature alteration and only 10 s epochs
were selected despite being too short to use in traditional methods
of HRV.19
A further paper in 200344 examined the ‘‘lockstep relationship’’
between scalp electroencephalographic spikes and alteration in
the R–R interval at that moment, comparing spike discharges from
the right and left hemispheres and found a direct effect of the inter-
ictal discharge on the R–R interval. Due to respiratory sinus
arrhythmia (RSA) it would have been methodologically improved if
R–R intervals were also measured from samples of the recording
that did not have any electrographic spike discharges to quantify
the effects of RSA.
Some patients are considered to be more pre-disposed to
cardiac arrhythmia and sudden death than others. A study by
Schwartz et al.45 demonstrated that a group of susceptible post
myocardial infarction dogs had reduced baroreﬂex sensitivity
prior to the infarction compared to resistant surviving dogs. La
Rovere et al.34 concluded from a large prospective study 30 days
post-infarction that reduced baroreﬂex sensitivity was a powerful
predictor of mortality for these patients over the following
2 years.
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This pilot study included eleven patients due to strict inclusion
criteria. Manual measuring of 27,151 R–R intervals (33 sub-clinical
seizures with 5-min matched baselines) also presented time
limitations of what was possible during this research period.
Automated peak detection software was considered but when
checked and re-measured manually, there were marked errors and
so manual measurement was preferred. In a report by the
American Heart Association,46 a consortium of European investi-
gators found systematic errors in measurement of 16 computer
programs for automated ECG analysis and reported that manual
measurement was often more accurate.
4.5. Effects of anti-epileptic medication
Ansakorpi et al.4 did not ﬁnd any changes in heart rate
variability from effects of anti-epileptic medication in their study
of temporal lobe epilepsy patients compared to controls but they
acknowledge that anti-epileptic medication are anticipated to
cause changes in cardiovascular regulatory function in some
patients due to blocking of sodium channels. This pilot study also
did not ﬁnd any signiﬁcant differences in CIPA results when
comparing patients who were being treated with anti-epileptic
medication to those not being treated with anti-epileptic
medication. The possible effects of anti-epileptic medication on
vagal tone cannot be fully evaluated due to the small scale of this
study.
4.6. Age effect on CIPA and HRV HF data
Effect could not be assessed adequately due to the small
number of patients included in this study. Normal data for
standardised CIPA or HRV have not been sufﬁciently established in
paediatrics in all age ranges. It has been reported47,48 that there is
an age-related alteration in cardiac vagal tone of an increase in
cardiac vagal tone between the ages of 3–6 years and then a
decrease from 6 to 15 years. However, numbers of patients
included in this normal data are also small and do not give account
of the wide intra and inter-subject variation in HRV49 and these
studies did not analyse HRV during speciﬁc sleep stages deﬁned
electrographically. Generalised data derived from two patients in
this study (aged 3 and 5 years) had lower cardiac vagal tone
compared to older paediatric patients. The two youngest patients
also had severe generalised epilepsy and therefore their data may
not be comparable to normal data. Toth et al50 describe lower HRV
in children with refractory epilepsy resulting from parasympa-
thetic tonus reduction and suggest that this may arise from
different mechanisms compared to adults. Unfortunately, no
generalised sub-clinical seizures in adults were captured. A larger
study would be required to ascertain whether adults also show an
increase in cardiac vagal tone during generalised sub-clinical
seizures as demonstrated by the children with generalised sub-
clinical seizures in this study.
4.7. Gender differences
Gender differences are considered unlikely to have made a
signiﬁcant difference to the results of this study because data was
not measured during Rapid Eye Movement (REM) stage sleep. A
study by Valladares et al.23 showed the only gender difference in
nocturnal vagal tone occurred in men during REM sleep where
there was a marked increase in cardiac sympathetic drive.
Despite these limitations this study has shown increased
parasympathetic activity and lower R–R variability during
generalised sub-clinical seizures compared to decreasedparasympathetic activity and increased R–R variability during
temporal lobe sub-clinical seizures.
4.8. Further study
Indications from this pilot study have offered a good basis for
further investigation with a large study of the differences between
generalised and temporal lobe sub-clinical seizures in the
continued investigation of possible autonomic mechanisms of
SUDEP. Nouri et al.39 underlines the importance of evaluating
autonomic cardiovascular and respiratory reﬂexes in people with
epilepsy and believes that it will provide invaluable insight into
some of the mechanisms of SUDEP. The Task Force of the European
Society of Cardiology and the North American Society of Pacing
and Electrophysiology19 believe that the task of assessing
transient changes in HRV seem to be more important than further
reﬁnements of HRV technology. Researchers analysing HRV must
use standardised methodology to enable comparisons in results
in various diseases and to increase knowledge of clinical
consequences.
5. Conclusion
In this pilot study we have demonstrated an alteration in
cardiac reﬂex and tonic vagal tone during sub-clinical seizures
compared to baseline measurements. Further research may bring
us closer to understanding the relationship between autonomic
dysfunction and SUDEP.
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